About

The problem of musculoskeletal disease is real, it is significant, and it demands  coordinated strategic response.

The Australian Institute for Musculoskeletal Science (AIMSS) strives to be the national leading  musculoskeletal institute. We conduct world-leading research, which translates into positive results that reduce the burden for people suffering from diseases of the muscles, bones and joints. For example, our pioneering research has designed, validated and tested new technologies and biomarkers for musculoskeletal diseases, which represent a breakthrough in the field. We have also identified new treatments for osteoporosis and sarcopenia, which are advancing into phase I and II trials.

This work is being translated into programs and initiatives which demonstrate significant positive impacts:

• New models of care for high risk patients. For example, implementation of a completely novel model of care for older persons at high risk for falls and fractures: The Falls and Fractures Clinic
• Prevention and Rehabilitation. For example, validation and implementation of the Gait and Balance Gym, an evidence-based model aimed to accelerate rehabilitation for post falls and fractures patients

Improved diagnosis and treatment. For example, integration of the new Osteoporosis Assessment Tools to be used by GPs all over Australia to diagnose osteoporosis and prevent fractures in older persons the care given is of a higher quality and is better coordinated, and people’s engagement with their care is also increased.

As a result Australians are more active, more productive, happier and healthier for more of their lives.